2021 MIPS Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey

Measure TypeHigh Priority Measure?Collection Type(s)
Patient Reported OutcomeyesMIPS CQM


Measure Description

Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after treatment


This measure is to be submitted each time a saphenous ablation procedure is performed for the treatment of varicose veins during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Measure Submission Type:

Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.


All patients who are treated for varicose veins with saphenous ablation and who receive an outcomes survey before and 3-6 months after treatment

Denominator Criteria (Eligible Cases):

All patients, regardless of age


Diagnosis for varicose veins (ICD-10-CM): I83.811, I83.812, I83.813, I83.819


Patient procedure during the performance period (CPT): 36465, 36473, 36475, 36478, 36482


Patients whose outcome survey score improved when assessed 3-6 months following treatment


Outcome Survey – A normalized and validated outcome survey developed for the patient reported outcomes for saphenous vein ablation. The disease specific standardized outcome survey utilized must be documented in the medical record. Examples of outcome surveys include, but are not limited to:

  • Venous Insufficiency Epidemiological and Economic Study-Quality of Life (VEINES-QOL)
  • Chronic Venous Insufficiency Questionnaire (CIVIQ)
  • Aberdeen Varicose Veins Questionnaire (AVVQ)
  • Specific Quality of Life and Outcome Response – Venous (SQOR-V)

Numerator Options:

Performance Met:

Patient survey score improved from baseline following treatment (G9603)


Denominator Exception:

Patient survey results not available (G9604)


Performance Not Met:

Patient survey score did not improve from baseline following treatment (G9605)


CMS-Interventional-Radiology-2021, CMS-Vascular-Surgery-2021, Diagnostic Radiology, Interventional Radiology-2021, Nuclear Medicine-2021, Quality-2021, Radiation Oncology-2021, Radiology-2021, Vascular Surgery-2021